Not exact matches
CML stem
cells, the cellular
source of a vast majority of
differentiated CML
cells, are reportedly responsible for the recurrence of CML, following TKI therapy.
«We have now found a novel
source of
cells that can
differentiate into coronary vessels and have identified the factors required.»
iPSCs directed to
differentiate into specific
cell types offer the possibility of a renewable
source of replacement
cells and tissues to treat ailments, including Parkinson's disease, spinal cord injury, heart disease, diabetes, and arthritis.
Human Embryonic Stem (hES)
cells derived from Preimplantation Genetic Diagnosed (PGD)- embryos offer a new alternative
source of cellular model as they can be largely expanded,
differentiated in several
cell types and harbors «naturally» the causative mutation of the pathology.
In the past, neural stem and progenitor
cells from various
sources were introduced into eyes with the thought that they might
differentiate and replace photoreceptors lost in retinal disease [13]--[19].